Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Cholewinski

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nuklearmedizin. Nuclear Medicine|October 14, 2004
Reduction of the LVEF measured with gSPECT after 1-3 hours after physical exercise in CADW Cholewinski, B Stefaniak, E Poniatowicz-Frasunek, et al.
Hellenic Journal of Nuclear Medicine|November 10, 2018
Images in two prostate cancer patients of second primary cancers: Hodgkin's lymphoma and lung adenocarcinomaP Cegla, E Wierzchoslawska, A Marszalek, et al.
European Journal of Nuclear Medicine|September 28, 2000
99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivativesC Decristoforo, S J Mather, W Cholewinski, et al.
Radiography (London, England : 1995)|April 25, 2024
[<sup>18</sup>F]fluorodeoxyglucose positron emission tomography/computed tomography in combination with clinical data in predicting overall survival in non-small-cell lung cancer patients: A retrospective studyP Cegla, G M Currie, W Cholewinski, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nuklearmedizin. Nuclear Medicine|October 14, 2004
Reduction of the LVEF measured with gSPECT after 1-3 hours after physical exercise in CADW Cholewinski, B Stefaniak, E Poniatowicz-Frasunek, et al.
Hellenic Journal of Nuclear Medicine|November 10, 2018
Images in two prostate cancer patients of second primary cancers: Hodgkin's lymphoma and lung adenocarcinomaP Cegla, E Wierzchoslawska, A Marszalek, et al.
European Journal of Nuclear Medicine|September 28, 2000
99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivativesC Decristoforo, S J Mather, W Cholewinski, et al.
Radiography (London, England : 1995)|April 25, 2024
[<sup>18</sup>F]fluorodeoxyglucose positron emission tomography/computed tomography in combination with clinical data in predicting overall survival in non-small-cell lung cancer patients: A retrospective studyP Cegla, G M Currie, W Cholewinski, et al.
Pageof 1